Ixico Plc Stock Net Income
| PHYOF Stock | USD 0.07 0.00 0.00% |
In connection with fundamental indicators, the technical analysis model lets you check practical technical drivers of IXICO plc, as well as the relationship between them.
IXICO Plc's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing IXICO Plc's valuation are provided below:IXICO plc does not now have any fundamental trends for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. IXICO |
IXICO Plc 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to IXICO Plc's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of IXICO Plc.
| 11/04/2025 |
| 02/02/2026 |
If you would invest 0.00 in IXICO Plc on November 4, 2025 and sell it all today you would earn a total of 0.00 from holding IXICO plc or generate 0.0% return on investment in IXICO Plc over 90 days. IXICO Plc is related to or competes with Hookipa Pharma, ImmunoCellular Therapeutics, and Propanc Biopharma. IXICO plc provides data analytics services to the biopharmaceutical industry in the United Kingdom, Switzerland, Netherl... More
IXICO Plc Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure IXICO Plc's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess IXICO plc upside and downside potential and time the market with a certain degree of confidence.
IXICO Plc Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for IXICO Plc's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as IXICO Plc's standard deviation. In reality, there are many statistical measures that can use IXICO Plc historical prices to predict the future IXICO Plc's volatility.IXICO plc Backtested Returns
We have found three technical indicators for IXICO plc, which you can use to evaluate the volatility of the firm. The company retains a Market Volatility (i.e., Beta) of 0.0, which attests to not very significant fluctuations relative to the market. the returns on MARKET and IXICO Plc are completely uncorrelated.
Auto-correlation | 0.00 |
No correlation between past and present
IXICO plc has no correlation between past and present. Overlapping area represents the amount of predictability between IXICO Plc time series from 4th of November 2025 to 19th of December 2025 and 19th of December 2025 to 2nd of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of IXICO plc price movement. The serial correlation of 0.0 indicates that just 0.0% of current IXICO Plc price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, IXICO plc reported net income of 1.03 M. This is 99.7% lower than that of the Healthcare sector and 98.53% lower than that of the Biotechnology industry. The net income for all United States stocks is 99.82% higher than that of the company.
IXICO Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses IXICO Plc's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of IXICO Plc could also be used in its relative valuation, which is a method of valuing IXICO Plc by comparing valuation metrics of similar companies.IXICO Plc is currently under evaluation in net income category among its peers.
IXICO Fundamentals
| Return On Equity | 0.0861 | |||
| Return On Asset | 0.0393 | |||
| Profit Margin | 0.12 % | |||
| Operating Margin | 0.11 % | |||
| Current Valuation | 8.91 M | |||
| Shares Outstanding | 48.35 M | |||
| Shares Owned By Insiders | 26.91 % | |||
| Shares Owned By Institutions | 57.90 % | |||
| Price To Earning | 12.50 X | |||
| Price To Book | 1.10 X | |||
| Price To Sales | 1.95 X | |||
| Revenue | 8.64 M | |||
| Gross Profit | 5.24 M | |||
| EBITDA | 1.56 M | |||
| Net Income | 1.03 M | |||
| Cash And Equivalents | 5.8 M | |||
| Cash Per Share | 0.12 X | |||
| Total Debt | 545 K | |||
| Debt To Equity | 0.05 % | |||
| Current Ratio | 5.96 X | |||
| Book Value Per Share | 0.26 X | |||
| Cash Flow From Operations | 1.42 M | |||
| Earnings Per Share | 0.02 X | |||
| Number Of Employees | 90 | |||
| Beta | 0.7 | |||
| Market Capitalization | 37.23 M | |||
| Total Asset | 14.65 M | |||
| Z Score | 40.8 | |||
| Net Asset | 14.65 M |
About IXICO Plc Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze IXICO plc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of IXICO Plc using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of IXICO plc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| VGIAX | Vanguard Growth And | |
| XAR | SPDR SP Aerospace | |
| XAR | SPDR SP Aerospace | |
| XAR | SPDR SP Aerospace | |
| ASML | ASML Holding NV |
Other Information on Investing in IXICO Pink Sheet
IXICO Plc financial ratios help investors to determine whether IXICO Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in IXICO with respect to the benefits of owning IXICO Plc security.